Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL) (PEARL)

This study has been completed.
Information provided by:
Ligand Pharmaceuticals Identifier:
First received: August 30, 2005
Last updated: August 8, 2011
Last verified: August 2011